Reuters

Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease

(Reuters) -Novartis said it has agreed to acquire U.S. biotech firm Chinook Therapeutics for up to $3.5 billion to boost its late-stage drug development line-up, raising the stakes in the race for a ...
Nasdaq

Novartis to buy Chinook for up to $3.5 bln in boost to late-stage pipeline

June 12 (Reuters) - Novartis NOVN.S said on Monday it agreed to acquire Seattle-based biotech firm Chinook Therapeutics KDNY.O for up to $3.5 billion to boost its late-stage drug development line-up ...
MarketWatch

Chinook Therapeutics stock surges on deal to be bought for up to $3.5 billion by Novartis

Shares of Chinook Therapeutics KDNY rose 67% to $40.02 after it agreed to be bought by Novartis NVS for up to $3.5 billion. Holders of Chinook will receive $3.2 billion, or $40 per share, in cash upon ...
Reuters

Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease

June 12 (Reuters) - Novartis (NOVN.S), opens new tab said it has agreed to acquire U.S. biotech firm Chinook Therapeutics (KDNY.O), opens new tab for up to $3.5 billion to boost its late-stage drug ...